M
Masami Nemoto
Researcher at University of Tokyo
Publications - 28
Citations - 337
Masami Nemoto is an academic researcher from University of Tokyo. The author has contributed to research in topics: Allylic rearrangement & Stereoselectivity. The author has an hindex of 10, co-authored 28 publications receiving 334 citations. Previous affiliations of Masami Nemoto include Tokyo University of Agriculture and Technology & Taisho Pharmaceutical Co..
Papers
More filters
Journal ArticleDOI
The protective effect of taurine on the biomembrane against damage produced by oxygen radicals.
TL;DR: It is suggested that taurine does not have an antioxidative effect like vitamin E, but interacts with the biomembrane, and helps to protect it against damage caused by AAPH, a water-soluble azo-compound.
Patent
Taste masking pharmaceutical composition for oral administration
TL;DR: In this paper, a composition for oral administration comprising an unpleasantly tasting drug, a high polymer soluble in the stomach and a monoglyceride in the.beta-crystal form was proposed.
Journal ArticleDOI
Influence of Wetting Factors on the Dissolution Behavior of Flufenamic Acid
TL;DR: The effects of surfactant, particle size, and additives on the dissolution rate of flufenamic acid were evaluated in relation to the time course of the available surface area and the probability parameters obtained were used to elucidate the influence of these factors on the surface characteristics of FFA quantitatively.
Journal ArticleDOI
Quantitative Evaluation of the Effectiveness of Taurine in Protecting the Ocular Surface against Oxidant
Katsu Nakamori,Ikuo Koyama,Tomomi Nakamura,Masami Nemoto,Tsuguchika Yoshida,Masato Umeda,Keizo Inoue +6 more
TL;DR: Quantitative evaluation of the effectiveness of taurine against ocular surface damage caused by hypochlorous acid (HOCl) was investigated using albino rabbits to prove objectively and quantitatively that t aurine is effective in protecting the ocularsurface against HOCl.
Patent
Composition for solid pharmaceutical preparations containing vitamin d3 derivative
TL;DR: In this article, the authors proposed a composition for solid pharmaceutical preparations containing a vitamin D3 derivative capable of permitting the derivative to be uniformly distributed in the composition while being stabilized, and the composition contains an excipient consisting of mannitol and sugar, a degradative agent consisting of hydroxypropyl cellulose, and a binder consisting of polyvinyl pyrrolidone and polypropylmethyl cellulose.